- Cool Tool – An Optimized, Chemically-Defined, Animal Component-Free Neural Basal MediumPosted 2 days ago
- Cool Tool – Lynx CDR Connectors to Improve Sterile Fluid Transfer in BiomanufacturingPosted 3 days ago
- Improving Glycosylation Patterns and Consistency Through Media OptimizationPosted 5 days ago
- Cool Tool – Online Cell Culture Media Formulation ToolPosted 1 week ago
- Video – Impact of Chemically Defined Media on Product QualityPosted 2 weeks ago
- Ask the Expert – Media Optimization Can Improve Glycosylation Patterns and Consistency to Impact Protein EfficacyPosted 2 weeks ago
- Digital Biomanufacturing Will Enable Tissue BioprintingPosted 3 weeks ago
- Video – When and Where to Optimize Cell Culture MediaPosted 4 weeks ago
- Cool Tool – SCOUT® technology reduces time to market and increases chance of success for biopharmaceutical productsPosted 4 weeks ago
- Pumping Iron – But Not in the gym: The Critical Roles of Transferrin in Cell Culture MediaPosted 1 month ago
Achieve gram per liter protein yields in a transient CHO system
CHO cells are the predominant host for biotherapeutic protein expression, with roughly 70% of licensed biologics manufactured in CHO. Multiple attributes make CHO cells desirable for bioproduction including the ability to adapt to high-density suspension culture in serum-free and chemically-defined media and the incorporation of post-translational modifications that are biologically-active in humans. For these reasons, the ability to produce transient CHO-derived proteins early on during drug development is highly advantageous to minimize, as much as possible, changes in protein quality/function observed when moving from R&D to bioproduction. Unfortunately, CHO cells express lower levels of protein than HEK293 cells in existing transient systems, in some instances 50-100 times less than the best 293-based systems. The recent introduction of the ExpiCHO transient expression system allows for unprecedented access to CHO-derived proteins early on during candidate selection and may serve to revolutionize the use of CHO cells for transient protein expression during the drug development process.
This Ask the Expert session is sponsored by Thermo Fisher Scientific, Inc and is hosted by Jonathan Zmuda, Ph.D., Associate Director of Cell Biology in the Life Sciences Solutions Group. Prominent among his roles, Dr. Zmuda leads a team dedicated to discovering and developing new technologies and products useful for cell biology applications including protein expression, cell culture, rare cell analysis and instrumentation. Dr. Zmuda received his Ph.D. in Cell Biology from the University of Maryland, College Park and his undergraduate degree from Dickinson College in Carlisle, PA.
Who should visit the session?
- Do you need a high-expressing transient CHO expression system for your work?
- Do you use 293 cells for drug candidate transient expression due to low levels of protein produced in transient CHO systems, even though your drug candidates will eventually be produced in CHO cells?
- Are post-translational modifications of proteins critical to your work?
- Do you encounter hard to express proteins that do not express well in 293 cells and would like another option to improve your protein titers?
If so, please take advantage of the opportunity to ask our expert a question and participate in a lively discussion on transient CHO expression.